Tirzepatide 20 mg is a subcutaneous injectable medication indicated for clinically supervised weight management and metabolic support in adults. Tirzepatide acts as a dual agonist of GLP-1 and GIP receptors, helping regulate appetite, enhance satiety, and improve metabolic control as part of a structured diet and lifestyle program.

This formulation is supplied in a pre-filled pen for subcutaneous administration, designed for once-weekly dosing under the supervision of a qualified healthcare professional. The medication must be stored refrigerated between 2°C and 8°C to maintain stability and effectiveness.

Manufactured under strict pharmaceutical-grade standards, Tirzepatide 20 mg ensures consistent potency, safety, and quality. It is a prescription-only medication and should be used only as directed by a licensed healthcare provider.

Key Features

• 20 mg subcutaneous injection

• Dual agonist targeting GLP-1 and GIP receptors

• Intended for once-weekly administration

• Supports appetite regulation and metabolic balance

• Requires refrigeration (2°C–8°C)

• Manufactured to pharmaceutical-grade standards

• Prescription-only, for supervised clinical use